HONOLULU — In patients with Barrett's esophagus, low-grade dysplasia carries a substantial risk for progression to esophageal adenocarcinoma, investigators report. The risk for progression in patients ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a patient ...
Bethesda, MD (May 17, 2024) — The American Gastroenterological Association’s (AGA) new evidence-based Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a new study published in The ...
The esophagus is the tube that connects your mouth to your stomach. Barrett’s esophagus is a condition where the tissue in your lower esophagus becomes damaged. It starts to resemble the tissue in ...
The American Gastroenterological Association's (AGA) new evidence-based Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia, published today in ...
A new epigenetic assay is able to stratify patients with Barrett's esophagus into lower-risk and higher-risk categories for progression to high-grade dysplasia or esophageal adenocarcinoma within 5 ...
A phase Ib/II study of fruquintinib in combination with SOX and toripalimab as first-line treatment for advanced metastatic gastric/gastroesophageal junction adenocarcinoma (GC/GEJC). Infusional ...
Strong recommendation for EET in patients with BE high-grade dysplasia based on available evidence. HealthDay News — In a clinical practice guideline issued by the American Gastroenterological ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback